Abstract
IN-VIVO EVALUATION OF PREGABLIN AND (S)-METHYL 3-(AMINOMETHYL)-5-METHYLHEXANOATE HYDROCHLORIDE USING ANIMAL MODELS
Dr. Syed Ahmed Hussain*, Juveria, Atika Tahreem and Ayesha Tanveer
ABSTRACT
Antiepileptic medications now on the market can treat 50 to 80 percent of epilepsy patients. 10-20% of patients who use these medications do not find any improvement in their seizure management. Extraction of compound chloroform has been severely delayed. COMPOUND reduced the amount of LPO. COMPOUND's antioxidant activities were revealed by a reduction in lipid peroxidation and an increase in glutathione levels in MES-initiated shaking models. Repeat seizures may be more frequent if the free radical rummaging movement dies. The neuronal mobility of the treated bunches differed from that of the standard, meo-, and high-dose COMPOUND bunches. As compared to the control, the compound dramatically increased the levels of GABA, as well as DA, NA, and 5-HT.
[Full Text Article] [Download Certificate]WJPLS CITATION 
| All | Since 2019 | |
| Citation | 422 | 322 |
| h-index | 9 | 7 |
| i10-index | 4 | 2 |
INDEXING
NEWS & UPDATION
BEST ARTICLE AWARDS
World Journal of Pharmaceutical and life sciences is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Article of current issue
Download Article : Click here